Skip to content

LSD: all studies

Page 41 of 282: studies 401 to 410 of 2,815, newest first. Back to the LSD overview

Research

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects

Frontiers in Pharmacology June 28, 2017 Patrick C. Dolder, Edna Grünblatt, Felix Müller et al. 12 citations

Rationale Renewed interest has been seen in the use of lysergic acid diethylamide (LSD) in psychiatric research and practice. The repeated use of LSD leads to tolerance that is believed to result from serotonin (5-HT) 5-HT2A receptor downregulation. In rats, daily LSD administration for 4 days decreased frontal cortex 5-HT2A receptor binding. Additionally, a single dose of LSD acutely increased...

Effects of LSD on music-evoked brain activity

bioRxiv (Cold Spring Harbor Laboratory) June 25, 2017 Mendel Kaelen, Romy Lorenz, Frederick S. Barrett et al. 20 citations preprint

Abstract Music is a highly dynamic stimulus, and consists of distinct acoustic features, such as pitch, rhythm and timbre. Neuroimaging studies highlight a hierarchy of brain networks involved in music perception. Psychedelic drugs such as lysergic acid diethylamide (LSD) temporary disintegrate the normal hierarchy of brain functioning, and produce profound subjective effects, including...

DOI: 10.1101/153031 (opens in new tab) Full text (opens in new tab) Active listening Sound perception Music psychology Cognitive psychology +5

Return of the lysergamides. Part III: Analytical characterization of N6-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P–ETH-LAD)

Drug Testing and Analysis May 10, 2017 Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. 44 citations

The psychoactive properties of lysergic acid diethylamide (LSD) have fascinated scientists across disciplines and the exploration of other analogues and derivatives has been motivated by deepening the understanding of ligand-receptor interactions at the molecular level as well as by the search for new therapeutics. Several LSD congeners have appeared on the new psychoactive substances (NPS)...

Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile

Human Psychopharmacology: Clinical and Experimental May 1, 2017 Leigh Coney, Larissa J. Maier, Jason Ferris et al. 18 citations

Abstract Objective This study aimed to describe self‐reported patterns of use and effects of lysergic acid diethylamide (LSD) analogues (AL‐LAD, 1P‐LSD, and ETH‐LAD) and the characteristics of those who use them. Methods An anonymous self‐selected online survey of people who use drugs (Global Drug Survey 2016; N = 96,894), which measured perceived drug effects of LSD and its analogues. Results...

Modern Clinical Research on LSD

Neuropsychopharmacology April 27, 2017 Matthias E. Liechti 230 citations

All modern clinical studies using the classic hallucinogen lysergic acid diethylamide (LSD) in healthy subjects or patients in the last 25 years are reviewed herein. There were five recent studies in healthy participants and one in patients. In a controlled setting, LSD acutely induced bliss, audiovisual synesthesia, altered meaning of perceptions, derealization, depersonalization, and mystical...

Introducing LSD, 1953–1956

University of Illinois Press April 20, 2017 Stephen Siff

This chapter studies the dramatic appearance of LSD on the news agenda in reports on scientific studies using drugs to simulate madness, and the concurrent discussion of mystical, mind-expanding drug use sparked by the publication of Aldous Huxley's Doors of Perception. In addressing these topics, journalists introduced American audiences to new drugs and to the use of drugs to create mental...

Luce, Leary, and LSD, 1963–1965

University of Illinois Press April 20, 2017 Stephen Siff 1 citation

This chapter details the celebrity coverage of Timothy Leary in the early 1960s and interest in LSD at Time and Life, where the publisher Henry Luce was becoming increasingly outspoken about his interest in the drug. Reporters often treated Leary—a Harvard psychologist removed from his job as a result of drug experimentation—with skepticism while still permitting him to explain the LSD...

DOI: 10.5406/illinois/9780252039195.003.0006 (opens in new tab) LSD Psychedelic Hallucinogen Mind-altering substance +17

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

Scientific Reports April 19, 2017 Michael Schartner, Robin Carhart-Harris, Adam B. Barrett et al. 450 citations

Abstract What is the level of consciousness of the psychedelic state? Empirically, measures of neural signal diversity such as entropy and Lempel-Ziv (LZ) complexity score higher for wakeful rest than for states with lower conscious level like propofol-induced anesthesia. Here we compute these measures for spontaneous magnetoencephalographic (MEG) signals from humans during altered states of...

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Translational Psychiatry April 4, 2017 Felix Mueller, Claudia Lenz, Patrick C. Dolder et al. 124 citations

Abstract Lysergic acid diethylamide (LSD) induces profound changes in various mental domains, including perception, self-awareness and emotions. We used functional magnetic resonance imaging (fMRI) to investigate the acute effects of LSD on the neural substrate of emotional processing in humans. Using a double-blind, randomised, cross-over study design, placebo or 100 μg LSD were orally...

Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience.

Medical Hypotheses March 1, 2017 Grzegorz R Juszczak 4 citations

LSD (lysergic acid diethylamide) is a model psychedelic drug used to study mechanism underlying the effects induced by hallucinogens. However, despite advanced knowledge about molecular mechanism responsible for the effects induced by LSD and other related substances acting at serotonergic 5-HT2a receptors, we still do not understand how these drugs trigger specific sensory experiences....